⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28069147 | 0.87 | — | — | |
| SCHEMBL7081970 | 0.83 | — | — | |
| SCHEMBL7081966 | 0.78 | — | — | |
| SCHEMBL8009 | 0.73 | — | — | |
| SCHEMBL6182462 | 0.73 | — | — | |
| SCHEMBL20211373 | 0.73 | — | — | |
| SCHEMBL2200048 | 0.71 | — | — | |
| Ammonia Solution, Strong SCHEMBL16110998 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL866240 | 0.71 | — | — | |
| SCHEMBL10479185 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101899026-B | Intermediates for the preparation of analogs of halichondrin B | 卫材R&D管理有限公司 | 2016-08-03 | — | — | CN | claimed |
| EP-2049689-B1 | NUCLEIC ACID AMPLIFICATION USING A REVERSIBLY MODIFIED OLIGONUCLEOTIDE | BI WANLI (US) | 2011-12-21 | — | — | EP | claimed |
| EP-0376870-A1 | A new organosilylpolyphosphoric reagent, its preparation and application to the process of synthesis of 3-carboxyquinolones or azaquinolones and their salts | CENTRO MARGA PARA LA INVESTIGACION S.A. (ES) | 1990-07-04 | — | — | EP | claimed |
| CN-113439084-B | Sesqui-carcinomycin analogue | 奥克兰联合服务有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-116669725-A | Novel aminopyridine and use thereof in the treatment of cancer | 奥克兰联合服务有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-112399977-B | Resin material for producing three-dimensional object and method of using the same | 清锋（北京）科技有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-112399977-A | Resin material for producing three-dimensional object and method of using the same | 清锋（北京）科技有限公司 | 2021-02-23 | — | — | CN | disclosed |
| WO-2020216034-A1 | INTERMEDIATE OF ERIBULIN, SYNTHESIS METHOD THEREFOR AND USE THEREOF | 北京天一绿甫医药科技有限公司 | 2020-10-29 | — | — | WO | disclosed |
| US-10752652-B2 | Method for preparing a ß-nucleoside compound | JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD. (CN) | 2020-08-25 | — | — | US | disclosed |
| CN-111330016-A | Antibody Drug Conjugates (ADC) that bind to 158P1D7 protein | 艾更斯司股份有限公司 | 2020-06-26 | — | — | CN | disclosed |
| CN-111330017-A | Antibody Drug Conjugates (ADC) that bind to 158P1D7 protein | 艾更斯司股份有限公司 | 2020-06-26 | — | — | CN | disclosed |
| CN-1976898-A | Spirolactam and synthesis thereof | ESTEVE LABOR DR (ES) | 2007-06-06 | — | — | CN | disclosed |
| CN-1620457-A | tetracyclic heterocyclic compounds as estrogen receptor modulators | ORTHO MCNEIL PHARM INC (US) | 2005-05-25 | — | — | CN | disclosed |
| CN-1200707-C | New use of taxoid derivatives | AVENTIS PHARMA (FR) | 2005-05-11 | — | — | CN | disclosed |
| CN-1105721-C | Preparation of narcotic analgesics | JOHNSON MATTEY PUBLIC LTD CO (GB) | 2003-04-16 | — | — | CN | disclosed |
| CN-1367691-A | New use of taxoid derivatives | AVENTIS PHARMA (FR) | 2002-09-04 | — | — | CN | disclosed |
| CN-1313764-A | New use of taxoid derivatives | AVENTIS PHARMA SA (FR) | 2001-09-19 | — | — | CN | disclosed |
| CN-1270586-A | Process for preparing taxoid derivatives | AWENTIS PHARMACEUTICAL S A (FR) | 2000-10-18 | — | — | CN | disclosed |
| CN-1231667-A | Preparation of narcotic analgesics | JOHNSON MATTEY PUBLIC LIMITED (GB) | 1999-10-13 | — | — | CN | disclosed |
| WO-1996016957-A1 | 3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-BENZOPYRAN-6-OL DERIVATIVES FOR USE AS DRUGS | PIERRE FABRE MEDICAMENT (FR) | 1996-06-06 | — | — | WO | disclosed |